medroxyprogesterone acetate has been researched along with Venous Thrombosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blondon, M; Heckbert, SR; McKnight, B; Psaty, BM; Rice, KM; Smith, NL; Van Hylckama Vlieg, A; Wiggins, KL | 1 |
| Helmerhorst, FM; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Archer, DF; Oger, E | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Cushman, M; Kuller, LH; Prentice, R; Psaty, BM; Rodabough, RJ; Rosendaal, FR; Sidney, S; Stafford, RS | 1 |
| Blackwell, RE | 1 |
| Oger, E; Plu-Bureau, G; Scarabin, PY; Simon, T | 1 |
| Andersen, TO; Eilertsen, AL; Høibraaten, E; Os, I; Sandset, PM; Sandvik, L | 1 |
| Szarewski, A | 1 |
| Jespersen, J; Nilas, L; Sidelmann, JJ; Skouby, SO | 1 |
| Alexandrou, AP; Bastounis, E; Bramis, J; Christodoulakos, GE; Creatsas, GC; Dalamanga, A; Keramaris, NC; Lambrinoudaki, IV | 1 |
| Lobo, RA | 1 |
| Cromer, B; Hewitt, G | 1 |
| Barrett-Connor, E; Cauley, J; Furberg, C; Grady, D; Haskell, W; Hulley, S; Hunninghake, D; Knopp, R; Lowery, M; Satterfield, S; Schrott, H; Vittinghoff, E | 1 |
4 review(s) available for medroxyprogesterone acetate and Venous Thrombosis
| Article | Year |
|---|---|
Estrogen and progestogen effect on venous thromboembolism in menopausal women.
Topics: Administration, Cutaneous; Age Factors; Aged; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Progestins; Risk Factors; Venous Thrombosis; Women's Health | 2012 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Menopause and stroke and the effects of hormonal therapy.
Topics: Aged; Estrogen Replacement Therapy; Estrogens; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Stroke; United States; Venous Thrombosis; Women's Health | 2007 |
Update on adolescent contraception.
Topics: Adolescent; Adolescent Behavior; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Postcoital; Drug Implants; Female; Humans; Medroxyprogesterone Acetate; Pregnancy; Venous Thrombosis | 2000 |
4 trial(s) available for medroxyprogesterone acetate and Venous Thrombosis
| Article | Year |
|---|---|
Estrogen plus progestin and risk of venous thrombosis.
Topics: Age Factors; Aged; Blood Coagulation Factors; Body Mass Index; Case-Control Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Obesity; Postmenopause; Proportional Hazards Models; Risk; Venous Thrombosis | 2004 |
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Topics: Administration, Cutaneous; Administration, Oral; Blood Coagulation; C-Reactive Protein; Drug Combinations; Estradiol; Estriol; Female; Hormone Replacement Therapy; Humans; Interleukin-6; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; P-Selectin; Risk Factors; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2005 |
The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Topics: Analysis of Variance; Blood Coagulation; Blood Coagulation Factors; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinolysis; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Thromboembolism; Venous Thrombosis | 2007 |
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Topics: Aged; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cause of Death; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Neoplasms; Postmenopause; Pulmonary Embolism; Risk Factors; Survival Analysis; Thromboembolism; Treatment Outcome; Venous Thrombosis | 2002 |
7 other study(ies) available for medroxyprogesterone acetate and Venous Thrombosis
| Article | Year |
|---|---|
Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: a population-based, case-control study.
Topics: Aged; Case-Control Studies; Estrogens, Conjugated (USP); Estrogens, Esterified (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Models, Cardiovascular; Postmenopause; Risk; Smoking; Thrombophilia; Venous Thrombosis; Washington | 2013 |
The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Risk Factors; Venous Thrombosis; Young Adult | 2010 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors; Venous Thrombosis | 2002 |
Estrogen plus progestin and risk of venous thrombosis.
Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Randomized Controlled Trials as Topic; Venous Thrombosis | 2005 |
Estrogen plus progestin and risk of venous thrombosis.
Topics: Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Risk; Venous Thrombosis | 2005 |
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.
Topics: Aged; Animals; Blood Coagulation; Estrogen Receptor Modulators; Estrogens, Conjugated (USP); Female; Hemostasis; Horses; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Thromboembolism; Venous Thrombosis | 2007 |